Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO 2 ): a randomized clinical trial.

European journal of heart failure(2022)

引用 13|浏览13
暂无评分
摘要
ClinicalTrials.gov Identifier: NCT04197635.
更多
查看译文
关键词
Dapagliflozin,Heart failure with reduced ejection fraction,Maximal functional capacity
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要